FI915677A0 - Foerfarande foer behandling av kataboliska patologiska processer i tarmkanalen. - Google Patents

Foerfarande foer behandling av kataboliska patologiska processer i tarmkanalen.

Info

Publication number
FI915677A0
FI915677A0 FI915677A FI915677A FI915677A0 FI 915677 A0 FI915677 A0 FI 915677A0 FI 915677 A FI915677 A FI 915677A FI 915677 A FI915677 A FI 915677A FI 915677 A0 FI915677 A0 FI 915677A0
Authority
FI
Finland
Prior art keywords
tarmkanalen
patologiska
kataboliska
processer
foerfarande foer
Prior art date
Application number
FI915677A
Other languages
English (en)
Inventor
Robert J Smith
Douglas W Wilmore
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23419606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI915677(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Publication of FI915677A0 publication Critical patent/FI915677A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Seasonings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Looms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Packaging Of Machine Parts And Wound Products (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI915677A 1989-06-02 1991-12-02 Foerfarande foer behandling av kataboliska patologiska processer i tarmkanalen. FI915677A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36083989A 1989-06-02 1989-06-02
PCT/US1990/003095 WO1990014823A1 (en) 1989-06-02 1990-06-04 Method of treating catabolic, gut-associated pathological processes and impaired host defenses

Publications (1)

Publication Number Publication Date
FI915677A0 true FI915677A0 (fi) 1991-12-02

Family

ID=23419606

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915677A FI915677A0 (fi) 1989-06-02 1991-12-02 Foerfarande foer behandling av kataboliska patologiska processer i tarmkanalen.

Country Status (16)

Country Link
EP (1) EP0401056B2 (fi)
JP (4) JP3068644B2 (fi)
KR (1) KR0178799B1 (fi)
AT (1) ATE160089T1 (fi)
AU (1) AU641403B2 (fi)
DE (1) DE69031694T3 (fi)
DK (1) DK0401056T4 (fi)
ES (1) ES2111529T5 (fi)
FI (1) FI915677A0 (fi)
GR (1) GR3025678T3 (fi)
HU (1) HU220214B (fi)
IL (1) IL94549A (fi)
NO (1) NO914730D0 (fi)
PT (1) PT94223B (fi)
WO (1) WO1990014823A1 (fi)
ZA (1) ZA904151B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JPH0569836U (ja) * 1992-02-25 1993-09-21 松下電工株式会社 ピアノハンドル式スイッチ
US5438075A (en) 1993-03-30 1995-08-01 Skubitz; Keith M. Oral glutamine to reduce stomatitis
EP0738146B1 (en) 1994-01-11 2003-05-02 N.V. Nutricia Method of treating disorders of the animal or human body by administering amino acids
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
GB0114419D0 (en) * 2001-06-13 2001-08-08 Mars Uk Ltd Health food
JP5473190B2 (ja) * 2003-10-16 2014-04-16 ネステク ソシエテ アノニム 化学療法又は放射線療法の副作用に対する栄養組成物
US8633192B2 (en) 2006-12-15 2014-01-21 Tima Foundation Compositions and uses thereof
CA2673054C (en) * 2006-12-15 2016-05-10 Tima Foundation Novel compositions and uses thereof
EP2612560A1 (en) 2012-01-09 2013-07-10 N.V. Nutricia Glutamine enriched nutritional composition for preterm infants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction

Also Published As

Publication number Publication date
HUT61193A (en) 1992-12-28
ES2111529T5 (es) 2007-11-16
EP0401056A3 (en) 1991-09-25
JP2000198733A (ja) 2000-07-18
EP0401056B2 (en) 2007-06-13
DK0401056T4 (da) 2007-07-16
EP0401056B1 (en) 1997-11-12
JP3113876B2 (ja) 2000-12-04
GR3025678T3 (en) 1998-03-31
JP2000186034A (ja) 2000-07-04
NO914730D0 (no) 1991-12-02
AU5827190A (en) 1991-01-07
JP3113877B2 (ja) 2000-12-04
JPH05500655A (ja) 1993-02-12
HU220214B (hu) 2001-11-28
IL94549A (en) 1996-08-04
DE69031694T2 (de) 1998-03-12
EP0401056A2 (en) 1990-12-05
JP3068644B2 (ja) 2000-07-24
PT94223B (pt) 1997-04-30
DE69031694D1 (de) 1997-12-18
JP3113878B2 (ja) 2000-12-04
KR920700629A (ko) 1992-08-10
WO1990014823A1 (en) 1990-12-13
IL94549A0 (en) 1991-03-10
ZA904151B (en) 1991-03-27
ES2111529T3 (es) 1998-03-16
ATE160089T1 (de) 1997-11-15
DE69031694T3 (de) 2007-10-18
KR0178799B1 (ko) 1999-03-20
DK0401056T3 (da) 1998-07-27
JP2000186035A (ja) 2000-07-04
AU641403B2 (en) 1993-09-23
PT94223A (pt) 1991-02-08

Similar Documents

Publication Publication Date Title
DK0862865T3 (da) Behandling af tobak
AR240255A1 (es) Un metodo de preservacion de virus vivos.
DE69111752D1 (de) Wiederaufschmelzlötofen.
DE69104652D1 (de) Wiederaufschmelzlötofen.
DE3853440D1 (de) Verfahren zur Wiedergewinnung von schaumigen Lösemitteln.
FI915677A0 (fi) Foerfarande foer behandling av kataboliska patologiska processer i tarmkanalen.
DE3689204D1 (de) Schaltung zur Korrektur von Rasterverzerrungen.
JPS6427474A (en) Plant virus or correction of its effect
IT1133069B (it) Procedimento e dispositivo per l estrazione e trattamento di materie solide da soluzioni o sospensioni particolarmente da acque di macellazione a scopo di ricupero
DE3761253D1 (de) Verfahren zur aufbereitung von kohle.
EP0608212A4 (en) PROCESS FOR TREATING VIRAL INFECTIONS.
NO891494D0 (no) Sett eller spill for komposisjon av tall, former og moenstre.
NO902691D0 (no) Kretsanordning for trening og drift av gassutladningslamper.
NO931246D0 (no) Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv)
DE69014057D1 (de) Verfahren zur Schmelzreduktion von Metallen und Schmelzreduktionsofen.
DE69101652D1 (de) Behandlungsofen.
CA2057055A1 (en) Method of treating catabolic, gut-associated pathological processes and impaired host defenses
DK154787D0 (da) Fremgangsmaade til ekstraktion af paraffiner fra blandinger af paraffiner og alkansulfonsyrer.
DE3787518D1 (de) Hochofenverfahren.
DE3868191D1 (de) Schaltung zur erzeugung einer fernsehbildpunktsynchronisation und ihre anwendung zur einblendung von zeichen.
DE3878137D1 (de) Behandlungsmethode zur bodenstabilisierung.
BR8501149A (pt) Processo e aparelho de extracao de latex de seringueiras
DE68921485D1 (de) Verfahren zur Rückgewinnung von Abgas einer Kohlefeuerung.
DE68909397D1 (de) Verfahren zur Steigerung des Wachstums von Hefe.
ATE96029T1 (de) Zusammensetzung und verfahren zur behandlung von hepatitisvirusinfektionen unter verwendung von 1(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5- ethyluracil.